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Abstract
Background: Approximately 70% of US adults currently receiving opioid agonist
treatment (OAT) for opioid use disorder are of reproductive age. Among women receiving
OAT at risk of having an unintended pregnancy, typically less than half report any current
contraceptive use compared to 90% in the general population. In addition, the rate of
unintended pregnancy among women receiving OAT is disproportionately higher than the
general population (~80% vs. 45%, respectively). Lack of knowledge about family
planning may be contributing to decreased rates of contraceptive use and increased rates
of unintended pregnancy among women receiving OAT.
Method: Participants were a convenience sample of women and men receiving OAT or a
comparison group receiving primary care (PC) services. Family planning knowledge was
assessed with the recently validated Contraceptive Knowledge Assessment (CKA), a selfadministered 25-question multiple-choice survey. A two-way ANOVA, with fixed factors
(i.e. patient sample and sex), compared the total number of correct responses for all
questions and five more specific content areas (p<.05).
Results: Overall, 332 participants completed this survey. The mean percent of total correct
responses was significantly lower in the OAT sample (n=167) compared to the PC sample
(n=165), 47% vs. 53% correct, respectively (p<.001) or approximately 1.5 questions less.
The mean percent of correct responses in four of the five content areas was also lower
among the OAT sample compared to the PC sample (ps<.01). The mean percent of total
correct responses was significantly higher among women (n=169) than men (n=163), 56%
vs. 44% correct, respectively (p<.0001) or approximately 3 questions more. The percent
of correct responses in four of the five content areas was also higher among women than
men (ps<.01).
Conclusion: Given the substantial discrepancy in rates of contraceptive use and
unintended pregnancy between individuals receiving OAT and the general population, it
is somewhat unexpected that individuals receiving OAT did not have lower levels of
family planning knowledge, although patients in both samples only answered
approximately 50% of the questions correctly. Results from the present study suggest
deficits in family planning knowledge, while statistically significant, may be less
clinically so. Overall, lack of family planning knowledge is likely only playing a small
role in population differences in contraceptive use and unintended pregnancy and
interventions aimed at decreasing these differences will need to address other barriers to
accessing family planning services and utilizing contraception in this population.
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Introduction

During the past several decades, significant advances in pharmacology and the
classification of pain as the “5th” vital sign have led to the exponential growth in the use of
prescription opioid medications (e.g. oxycodone, fentanyl) to treat and manage pain. This
proliferation has contributed to alarming rates of misuse of opioid medications, heroin use,
and the prevalence of overdose deaths which preempted the US Department of Health and
Human Services to declare the opioid crisis a nationwide Public Health Emergency in 2017
(Center for Behavioral Health Statistics and Quality, 2018; Hedegaard, Warner, & Minino,
2017; Martins et al., 2017; US Department of Health and Human Services, 2017).
Approximately 66% of the more than 11 million individuals who reported misuse of
opioids (i.e. misuse of prescription opioid medication and/or heroin use) during the past
year are women and men of reproductive age (15-45 years old; Center for Behavioral
Health Statistics and Quality, 2018). Most alarmingly, between 1999 and 2017, the rate of
opioid-related overdose deaths increased more than 500% for individuals of reproductive
age (Centers for Disease Control and Prevention, 2019a).

A Note about Terminology and Classification
Before continuing, it is important to briefly review terminology associated with
descriptions of opioid misuse and treatment, as there have been many changes in recent
years. Prior to 2013, the Diagnostic and Statistical Manual of Mental Disorders (DSM)
described maladaptive patterns of opioid use, both nonmedical use of prescription opioid
medication and heroin use, in terms of abuse and dependence. When the newest version of
1

the DSM was published in 2013 (DSM-5), substance use-related diagnostic criteria,
including opioid use, changed significantly. The DSM-5 combined abuse and dependence
into a single category and measures severity of use on a continuum (American Psychiatric
Association, 2013). These changes represent a major paradigm shift in how opioid and
other substance use disorders are conceptualized (i.e. a chronic, relapsing disease). This
diagnostic reclassification has also resulted in ongoing changes to the terminology used to
describe opioid misuse. Professional organizations including the American Medical
Association and the American Society of Addiction Medicine have endorsed the use of
phrases such as nonmedical use of opioids, individuals with opioid use disorder (OUD),
medication treatment for OUD (i.e. methadone, buprenorphine, naloxone), and opioid
agonist treatment (OAT; i.e. methadone or buprenorphine) and recommend the
abandonment of terms like addict, abuse, replacement therapy, and substitution treatment
(American Society of Addiction Medicine, 2015; Olsen & Sharfstein, 2014; Substance
Abuse and Mental Health Services Administration, 2015). Using appropriate language to
describe opioid misuse supports reduction of stigma, prejudice, and judgment. However,
from a research perspective, variations in language and classification criteria over the years
create methodological issues in terms of comparing studies and making inferences about
study outcomes. For the purposes of this study, contemporary language will be used as
much as possible to describe this population and prior research outcomes.

Opioid Misuse and Unintended Pregnancy
Approximately 70% of US adults currently receiving OAT are of reproductive age
(Substance Abuse and Mental Health Services Administration, 2017). Although opioid
2

misuse negatively impacts both women and men (Rudd, Aleshire, Zibbell, & Matthew
Gladden, 2016; Seth, Rudd, Noonan, & Haegerich, 2018; Whiteman et al., 2014;
Winkelman, Chang, & Binswanger, 2018), reproductive-age women can be affected in
unique ways (see review by Back, Lawson, Singleton, & Brady, 2011; Jarlenski et al.,
2017; Jones, Tuten, Keyser-Marcus, & Svikis, 2006; Kozhimannil, Graves, Jarlenski, et
al., 2017). One way that has historically received relatively little attention is the high rate
of unintended pregnancy in this population. Unintended pregnancy is a broader term that
collectively refers to pregnancies that are mistimed (i.e. occurring earlier than the woman
desired) or unwanted (i.e. occurring even though the woman did not desire it) (Santelli et
al., 2003).
The health implications of planning a pregnancy are significant. Women who do
not plan their pregnancies are less likely to engage in health-promoting behaviors during
the preconception and perinatal periods compared to women with intended pregnancies
(Cheng et al., 2016; Dott et al., 2010; Orr, James, & Reiter, 2008; Rassi, Wattimena, &
Black, 2013). For example, unintended pregnancies are associated with delayed prenatal
care (Cheng, Schwarz, Douglas, & Horon, 2009; Lindberg, Maddow-Zimet, Kost, &
Lincoln, 2015) and decreased use of prenatal vitamins (Dott et al., 2010). Women who
report having an unintended pregnancy are also less likely to initiate and continue
breastfeeding compared to women who plan their pregnancies (Lindberg et al., 2015) and
prenatal and postpartum maternal depression are more prevalent (Abajobir, Maravilla,
Alati, & Najman, 2016; Cheng et al., 2009; Fellenzer & Cibula, 2014; McCrory &
McNally, 2013).
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In the first large-scale estimate of the prevalence of unintended pregnancy among
pregnant women reporting recent opioid misuse, pregnancy intention was assessed in
approximately 1000 pregnant women screened for enrollment in the MOTHER study, a
multi-site randomized, controlled trial comparing OAT (i.e. methadone versus
buprenorphine) for the treatment of opioid misuse during pregnancy (Heil et al., 2011).
Results indicated that almost 9 of every 10 pregnancies were unintended (86%). This is in
striking contrast to women in the general population who report 45% of their pregnancies
are unintended (Finer & Zolna, 2016). Subsequent studies with women receiving OAT
have consistently reported results similar to the Heil et al. (2011) study, with the rate of
unintended pregnancy averaging nearly 80% across reports (Black, Stephens, Haber, &
Lintzeris, 2012; Fischbein et al., 2018; Kreitinger et al., 2016; Meschke, McNeely, Brown,
& Prather, 2018; Smith, Morse, & Busby, 2019; Welle-Strand et al., 2013, 2015).

Opioid Misuse and Pregnancy
Prevalence. Increasing rates of opioid misuse among women of reproductive age
coupled with high rates of unintended pregnancy have inevitably led to increases in opioid
misuse by pregnant women. Rates of opioid misuse have, not surprisingly, also contributed
to the high prevalence of OUD during pregnancy and the subsequent need for treatment
(Kozhimannil, Graves, Levy, & Patrick, 2017; see review by Krans & Patrick, 2016; Metz,
Brown, Martins, & Palamar, 2018; Pan & Yi, 2013). Nationally, it is estimated that the
prevalence of maternal OUD at hospital delivery has more than quadrupled from 1999 to
2014 (Haight, Ko, Tong, Bohm, & Callaghan, 2018).
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Consequences. Opioid misuse during pregnancy even among women receiving
OAT, is often compounded by a multitude of factors, such as other drug use (Davie-Gray,
Moor, Spencer, & Woodward, 2013), poor prenatal care (Parlier, Fagan, Ramage, &
Galvin, 2014; Roberts & Pies, 2011), psychiatric symptoms (Benningfield et al., 2012;
Whiteman et al., 2014), and low socioeconomic status (SES; Corr & Hollenbeak, 2017;
Hand, Short, & Abatemarco, 2017; Martin, Longinaker, & Terplan, 2015), that collectively
contribute to adverse consequences for the infant, including premature delivery and low
infant birth weight (Metz et al., 2018; Patrick et al., 2015; Saia et al., 2017; Yazdy, Desai,
& Brogly, 2015). In addition, infants exposed to opioids in utero may develop neonatal
abstinence syndrome (NAS), a generalized disorder characterized by signs of central
nervous system hyperirritability, gastrointestinal dysfunction, respiratory distress, and
autonomic dysregulation (Finnegan, Connaughton, Kron, & Emich, 1975), that often
requires extended hospitalization (typically 4 days) for monitoring and treatment (see
review by Bagley, Wachman, Holland, & Brogly, 2014; Jones et al., 2010; Kelty & Hulse,
2017; Patrick, Kaplan, Passarella, Davis, & Lorch, 2014; Patrick et al., 2016; Substance
Abuse and Mental Health Services Administration, 2018; Tolia et al., 2015). Not
surprisingly, as maternal OUD has increased, so has the number of infants diagnosed with
NAS. For example, between 2004 to 2014, the national incidence of NAS increased more
than five-fold, from 1.5 to 8.0 per 1000 hospital births (Winkelman, Villapiano,
Kozhimannil, Davis, & Patrick, 2018). In addition, poor birth outcomes and prolonged
monitoring and treatment add significantly to acute medical costs. It is estimated that
aggregate hospital charges for NAS treatment were approximately $1.5 billion/year in 2012
dollars, with the majority of costs covered by Medicaid (Patrick, Davis, Lehman, &
5

Cooper, 2015). The most recent estimates suggest the costs of hospital admission for an
infant with NAS are more than 2.5 times greater than that for an infant without NAS (Corr
& Hollenbeak, 2017).
More generally and longer term, bearing a child in disadvantaged circumstances
like those of many women receiving OAT significantly diminishes the future wellbeing of
both the mother and the child. For a woman growing up in circumstances of lower SES,
the frequent occurrence of early motherhood and single motherhood increase the risk of
persistent disadvantage for her but also for her children, while a woman from a higher SES
background is more likely to postpone cohabitation and parenthood and thereby maintain
a higher SES (Tough, Vekved, & Newburn-Cook, 2012). Overall, unintended pregnancy
among women receiving OAT is associated with significant short- and long-term
consequences of extraordinary cost for both mother and child.

Family Planning
The purpose of family planning is to support women and their male partners in
achieving the number and spacing of children they desire (Gavin & Moskosky, 2014).
Family planning includes information about fertility awareness, contraceptive services,
pregnancy testing and counseling, basic infertility services, sexually transmitted infection
(STI) services and other preconception and preventive health services (Gavin et al., 2014).
As the average woman spends about three decades of her life trying to avoid unintended
pregnancy (Sonfield, Hasstedt, & Gold, 2014), the overwhelming majority of family
planning services are in the areas of fertility awareness and contraception.

6

Fertility awareness. Recognizing and understanding a woman’s fertility is an
important component of family planning because it maximizes a woman’s (or couple’s)
control of whether and when to have children (Gavin et al., 2014). The only time a woman
can become pregnant is during ovulation, colloquially referred to as the “fertile window”
of the menstrual cycle. Consequently, many women/couples time intercourse and
determine whether or not to use contraception based on the status of the woman’s menstrual
cycle (Lundsberg et al., 2014; Mosher, Jones, & Abma, 2015; Nettleman, Chung, Brewer,
Ayoola, & Reed, 2007; Pallone & Bergus, 2009; Righarts, Dickson, Parkin, & Gillett,
2017; Smoley & Robinson, 2012). However, these strategies can be problematic if fertility
awareness and other knowledge about the biological processes of conception (e.g. how
long sperm survive) are inaccurate. Women with OUD, even those receiving OAT, often
report lower perceived risk of becoming pregnant because of opioid use (Harding &
Ritchie, 2003; Olsen, Banwell, & Madden, 2014), but little is known about their fertility
awareness or whether it is associated with their contraceptive use.
Contraceptive services. Contraceptive services revolve primarily around
contraceptive methods. There are many different contraceptive methods with varying
levels of effectiveness currently available in the US, the majority of which need to be
prescribed by qualified healthcare providers. Most contraceptive methods are for use by
women, but at least two methods (i.e. male sterilization and male condoms) are for men
(Curtis, Tepper, et al., 2016). Female and male sterilization are highly effective methods
(Figure 1, Tier 1, tubal occlusion and vasectomy), with greater than 99% pregnancy
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Figure 1. Contraceptive Method Effectiveness. Reprinted from Efficacy, Safety, and
Personal Considerations. In: Hatcher R.A. Hatcher, eds. Contraceptive Technology.
21st ed. New York, NY: Ayer Company Publishers, Inc.

prevention within the first year of typical use, but these methods are not reversible. The
most effective, reversible contraceptive methods are implants and intrauterine devices
(IUDs; Figure 1, Tier 1) often collectively referred to as long-acting reversible
contraception (LARC) because they are effective for a minimum of three years and fertility
is rapidly restored upon removal. Their <1% failure rate is due in part to the fact that after
placement, they require virtually no effort on the woman’s part. Despite different types of
LARCs being available for many years, use of these methods has historically been very
low due to early design flaws, undesirable side effect profiles, and complications associated
with placement and removal (Shoupe, 2016). Fortunately, newer models have improved
8

significantly in recent years. The levonorgestrel IUD was approved for use in 2000 and the
single-rod implant was approved in 2006. In addition, availability of the copper IUD
increased after 2005 due to labeling revisions that removed several major contraindications
of use (Waknine, 2005). Other reversible contraceptive methods, including pills, patch,
ring, and injectables (Figure 1, Tier 2), are less effective than LARCs or sterilization, but
more effective than male condoms and withdrawal, two of the least effective methods for
preventing pregnancy (Figure 1, Tier 3). It is important to note that, when used correctly,
male condoms can provide dual protection against both pregnancy and STIs. For example,
male condoms reduce the risk of HIV transmission by approximately 90% (USAID, 2015).
However, specific to pregnancy prevention, male condoms and other non-LARC methods
(e.g. pills) are more prone to user error and imperfect adherence, both of which decrease
their overall effectiveness, leading to estimated pregnancy rates of 13% for male condoms
and 7% for pills in the first year of typical use (Trussell & Aiken, 2018).
Finally, although not typically described as a method of birth control, emergency
contraception pills, sometimes referred to as Plan B or colloquially as the “morning after
pill,” are a post-coital method used to avoid an unintended pregnancy. The majority of
emergency contraception pills currently available are effective if a woman uses them
within 72 hours of unprotected intercourse; it does not have an effect on an established
pregnancy (Haeger, Lamme, & Cleland, 2018; Trussell, Cleland, & Schwarz, 2018).
Prevalence of family planning methods.
General population. Approximately 65% of all women of reproductive age in the
general population report they or their partner are currently using contraception; this rises
to 90% among the subset of women at highest risk of unintended pregnancy (i.e. women
9

currently having intercourse, not pregnant or trying to conceive, and not sterile for noncontraceptive reasons; Kavanaugh & Jerman, 2018). Most women are medically eligible
for 10 or more contraceptive method options (Trussell, Aiken, Micks, & Guthrie, 2018)
and therefore typically have many choices. The most common contraceptive methods
women report currently using are pills (25%), female sterilization (22%), male condoms
(15%), LARCs (14%), and male sterilization (7%; Kavanaugh & Jerman, 2018). Only 8%
of women report use of multiple contraceptive methods, most often male condoms
combined with another method (Guttmacher Institute, 2016). Approximately 20% of
women report ever using emergency contraception (Centers for Disease Control and
Prevention, 2019b).
Turning to men, the most common contraceptive methods men report they or their
partner used at last intercourse are male condoms (35%), male sterilization (22%), and pills
(21%; Stewart, Ritter, Bateson, McGeechan, & Weisberg, 2017). While most contraceptive
methods are for use by women and there is a tendency to think of contraception solely as a
woman’s responsibility (Brown, 2015; Fennell, 2011; Forste, 2003; Green & Biddlecom,
2000; Hamm et al., 2019; Oudshoorn, 2004), research suggests that both men and women
influence couple method choice and consistency of use (Grady, Klepinger, Billy, &
Cubbins, 2010; Grady, Tanfer, Billy, & Lincoln-Hanson, 1996; Nguyen & Zaller, 2009;
Wigginton, Harris, Loxton, & Lucke, 2018; Zolna, Lindberg, & Frost, 2011). Indeed, the
majority of men report they want to participate in decisions related to contraception to
address prevention of both pregnancy and STIs and believe men and women share this
responsibility (Forste & Morgan, 1998; Grady et al., 1996; James-Hawkins, Dalessandro,
& Sennott, 2019; Landry & Camelo, 1994; Richards, Peters, Sheeder, & Kaul, 2016;
10

Stewart et al., 2017). Furthermore, there is some research to suggest that contraceptive use
may increase when male partners are involved in decision making about contraception
(Widman, Welsh, McNulty, & Little, 2006).
Individuals receiving OAT. Contraceptive use is not contraindicated for women
receiving OAT (Curtis, Jatlaoui, et al., 2016), although a systematic review of
contraceptive use among women with opioid and other substance use disorders suggests
that only about half report current contraceptive use (Terplan, Hand, Hutchinson,
Salisbury-Afshar, & Heil, 2015). The overall prevalence of current contraceptive use
among women receiving OAT has been reported to range between 25-56% (Black et al.,
2012; Cornford, Close, Bray, Beere, & Mason, 2015; Harding & Ritchie, 2003; Krans et
al., 2018; Morrison, Ruben, & Beeching, 1995; Poulton, Parlier, Scott, Fagan, & Shelley,
2015; Ralph & Spigner, 1986). These rates are 2-2.5 times lower than rates reported by
comparison groups of the general population (49-75%) (Cornford et al., 2015; Krans et al.,
2018; Ralph & Spigner, 1986). Furthermore, only approximately 50% of women receiving
OAT who are at risk of unintended pregnancy (i.e. women currently having intercourse,
not pregnant or trying to conceive, and not sterile for non-contraceptive reasons) report
current contraceptive use, which is almost half the rate of contraceptive use reported by
women at risk in the general population (90%; Black et al., 2012; Kavanaugh & Jerman,
2018; Poulton et al., 2015).
The method women receiving OAT most commonly report using are male condoms
(Black et al., 2012; Cornford et al., 2015; Fischbein et al., 2018; Harding & Ritchie, 2003;
Morrison et al., 1995), although the high rate of unintended pregnancy among individuals
with OUD suggests a general lack of effective condom use in this population (Bradshaw,
11

Pierce, Tabrizi, Fairley, & Garland, 2005; Edelman, Patel, Glasper, & Bogen-Johnston,
2014) as do high rates of STIs (Feaster et al., 2016; Lewis, Wu, & Ethelyn Strong, 2017;
Novak, Ball, Winstock, & Peiper, 2016). There is very little information in the literature
about the rates of current use of other contraceptive methods. The best estimate to date
may be a large study by Cornford et al. (2015) where methods included female sterilization
(23%), combined pills/patch/ring (22%), injectables (19%), and LARCs (18%). Although
the data regarding the types of contraceptive methods women receiving OAT report using
is extremely limited, these percentages suggest that when women receiving OAT do use
contraception, they are using it at rates similar to the general population.
In the one study we are aware of regarding contraceptive use reported by men
receiving OAT, approximately a third of the men reported consistently using male condoms
(Gilbert, El-Bassel, Wu, & Chang, 2007), similar to estimates of men in the general
population (Reece et al., 2010). To our knowledge, there are no studies that assess female
partner contraceptive use reported by men receiving OAT. Overall, these results suggest a
large percentage of women and men receiving OAT do not use contraception at all, or use
it inconsistently and/or ineffectively, thereby greatly increasing their risk of unintended
pregnancy and STIs.

Barriers to Contraceptive Use
There are multiple barriers that interfere with women obtaining and effectively
using contraception including barriers to accessing services, poor fertility awareness, lack
of knowledge about contraception (i.e. efficacy, mechanisms of action, safety), and
partner-related factors (Ayoola, Nettleman, & Brewer, 2007; Beckman & Harvey, 1996;
12

Biggs, Karasek, & Foster, 2012; Frank, Poindexter, & Bateman, 1993; Frost & Darroch,
2008; Frost, Lindberg, & Finer, 2012; Goodman, Onwumere, Milam, & Peipert, 2017;
Johnston & Howie, 1985; Kakaiya, Lopez, & Nelson, 2017; Leeman, 2007; Marshall,
Kandahari, & Raine-Bennett, 2018; Matteson & Hawkins, 1997; Maxwell, Devries, Zionts,
Alhusen, & Campbell, 2015; Moreau, Cleland, & Trussell, 2007; Mosher et al., 2015;
Nettleman et al., 2007; Pritt, Norris, & Berlan, 2017; Rosenberg, Waugh, & Meehan, 1995;
Silverman, Torres, & Forrest, 1987; Stewart et al., 2017; Tanfer, 1994; Trussell, Stewart,
Guest, & Hatcher, 1992; Widman et al., 2006; Zelnik & Kantner, 1979). Although more
research is necessary to determine why individuals receiving OAT report low rates of
contraceptive use overall, the data we do have suggests that barriers of contraceptive use
reported by women receiving OAT are very similar to those reported by women in the
general population (Bornstein, Gipson, Bleck, Sridhar, & Berger, 2019; Matusiewicz,
Melbostad, & Heil, 2017; Meschke et al., 2018; Poulton et al., 2015; Smith et al., 2019).
Our group’s initial foray into research to reduce unintended pregnancy among
women receiving OAT focused on reducing access barriers. We devised a novel, intensive
experimental family planning intervention informed by behavioral economic theory aimed
at increasing both contraception initiation and continuation primarily by co-locating free
family planning services with an OAT clinic. Results from both the initial Phase Ib trial
(Heil et al., 2016) and an ongoing Phase II trial suggest eliminating access barriers greatly
increases the use of contraception in this population. Nevertheless, results from the ongoing
trial indicate that approximately 40% of women are not using contraception effectively at
the end of the intensive intervention. As a result, we have been considering various
modifications to the intervention in an effort to increase efficacy. Our anecdotal experience
13

with more than 175 participants in our trials to date suggests that poor fertility awareness
and deficits in contraceptive knowledge among both the female participants and their male
partners may be a contributing factor to the lower rates of contraceptive use in this
population. Indeed, the scientific literature confirms that there is a dependable relationship
between fertility awareness and contraceptive knowledge (hereafter referred to collectively
as family planning knowledge) and contraceptive use.
General population. Poor family planning knowledge, including misperceptions
and/or lack of awareness about the efficacy, mechanisms of action, safety, and potential
side effects associated with contemporary contraceptive methods, is reliably associated
with incorrect or inconsistent use and method discontinuation among women and men
(Ayoola et al., 2007; Biggs & Foster, 2013; Callegari, Aiken, Dehlendorf, Cason, &
Borrero, 2017; Carter, Bergdall, Henry-Moss, Hatfield-Timajchy, & Hock-Long, 2012;
Dempsey, Billingsley, Savage, & Korte, 2012; Eisenberg et al., 2012; Foster et al., 2004;
Foster, Ralph, Arons, Brindis, & Harper, 2007; Gilliam, Warden, Goldstein, & Tapia,
2004; Grimes & Schulz, 2010; Hauck & Costescu, 2015; Hladky, Allsworth, Madden,
Secura, & Peipert, 2011; Jaccard, Helbig, Wan, Gutman, & Kritz-Silverstein, 1996;
Johnston & Howie, 1985; Jones, Darroch, & Henshaw, 2002; Kakaiya et al., 2017; Kollar,
Biro, Boehner, & Rosenthal, 2000; Levinson, 1995; Lundsberg et al., 2014; Mackin, Clark,
McCarthy, & Farris, 2015; Merchant et al., 2007; Mosher et al., 2015; Rosenberg et al.,
1995; Schrager et al., 2015; Tanfer, 1994). For example, in a study of contraceptive
knowledge among a nationally representative sample of young adults, each additional
correct response on a contraceptive knowledge scale was associated with a 17% increase
in women using prescription contraception at their next sexual encounter; among men, the
14

likelihood of them having a partner who was using a prescription method was associated
with an 11% increase (Frost et al., 2012). In addition, women in this study who
underestimated the effectiveness of oral contraception (i.e. birth control pills) were more
than twice as likely to report expecting to have unprotected intercourse in the next three
months compared to women who accurately estimated the effectiveness of oral
contraception. As another example, among a large convenience sample of women seeking
primary care services, women who had never used an IUD were five times more likely to
possess inaccurate knowledge about IUD effectiveness compared to current IUD users
(Callegari, Parisi, & Schwarz, 2013).
Individuals receiving OAT. Information about family planning knowledge among
women receiving OAT is very limited and to our knowledge there are no data available
with respect to men. In one qualitative study that investigated knowledge, attitudes, and
beliefs about family planning among women enrolled in three substance abuse treatment
programs in Baltimore, MD, at least one of which provided OAT, women demonstrated
some knowledge about various methods, but also numerous misconceptions and
inaccuracies (Robinowitz, Muqueeth, Scheibler, Salisbury-Afshar, & Terplan, 2016). For
example, one woman accurately recalled information about different types of LARCs and
described several benefits of using these methods, but other women reported inaccurate
information about the efficacy of birth control pills and injectables and expressed
uncertainty about using these methods. These results suggest that misinformation may be
contributing to low rates of contraceptive use among women in treatment for OUD.
Two quantitative studies, one of which we published, both utilized items from an
earlier survey (i.e. the National Campaign to Prevent Teen and Unplanned Pregnancy’s
15
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Injectables
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Figure 2. Correct Responses to Contraceptive
Knowledge Questions as a Function of Method Type.
Reprinted from “Knowledge of and concerns about longacting reversible contraception among women in
medication-assisted treatment for opioid use disorder,”
by A. Matusiewicz, 2017, Contraception, 96, 365-369.

49 years old, who were
patients at the Chittenden
Clinic, a large, outpatient
OAT facility in Burlington,
VT and who completed an

eligibility screening for our ongoing randomized clinical trial described earlier. Overall,
women receiving OAT knew as much about IUDs as short-acting methods and male
condoms, but knowledge about implants was consistently lower than all other methods
assessed (Figure 2).

Knowledge about male condoms, pills, injectables, and IUDs

appeared very similar to that reported by women in the National Campaign sample (Kaye,
Suellentrop, & Sloup, 2009), although the National Campaign sample was limited to
unmarried women between the ages of 18 and 29.
Utilizing some of the same survey items, Meschke et al. (2018) recently published
results generally consistent with our findings. Women 18-45 years old receiving OAT
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services from two different clinics in eastern Tennessee were invited to participate.
Responses to items assessing knowledge about specific contraceptive methods were
aggregated to form an overall knowledge score, although they did include a subset of
questions specifically about IUDs. Women in this study answered approximately 60% of
the questions about overall knowledge correctly and 42% of the IUD questions correctly.
While these studies provide important preliminary information about levels of
contraceptive knowledge among women receiving OAT, there are several limitations that
should be noted. First, differences in methodology between the two quantitative studies
prevent a direct comparison of results. For example, Matusiewicz et al. (2017) published
data about knowledge of individual methods compared to the emphasis on overall
knowledge by Meschke et al. (2018). Second, women in both studies were only asked about
some methods (e.g. there are no questions about emergency contraception) and there were
no questions about fertility awareness. Third, no data were collected from men in either
study. Finally, neither study included a comparison group, which compromises the ability
to place results in a larger context.

Assessment of Family Planning Knowledge
While many studies have found a positive association between family planning
knowledge and contraceptive use, it is interesting to note that there is no commonly-used
tool to assess fertility awareness or to measure contraceptive knowledge. For example,
results from a systematic review of 21 studies that assessed measurement of knowledge
about oral contraception could not identify a gold-standard tool or best practices measure,
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in part due to an almost complete lack of validity and reliability testing (Hall, Castaño,
Stone, & Westhoff, 2010).
Recently, Haynes and colleagues published the Contraceptive Knowledge
Assessment (CKA; Appendix; Haynes, Ryan, Saleh, Winkel, & Ades, 2017). Although
the title of the CKA specifies “contraceptive knowledge,” this 25-item, multiple-choice
measure assesses family planning knowledge more broadly, including fertility awareness,
contraceptive method knowledge (including all contemporary methods), and pregnancy
prevention self-efficacy. Validity of this novel assessment tool was established primarily
by expert review (Haynes et al., 2017). Among study participants, test-retest analysis
revealed no significant difference in total mean score and the high correlation between
initial and follow-up administration of the CKA (R=0.79, p=.667) demonstrates good
reliability for the assessment of family planning knowledge (Haynes et al., 2017).
In addition to providing a total CKA score, our examination of CKA questions
suggests that many could be grouped together to provide information about knowledge in
particular content areas that may help identify specific deficits in knowledge. Independent
expert review by two board certified obstetrician/gynecologists identified five categories:
1) fertility awareness, 2) general contraceptive knowledge, 3) short-acting contraception
knowledge, 4) long-acting reversible contraception knowledge, and 5) other contraceptive
methods knowledge (Table 1).
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Table 1. Distribution of Contraceptive Knowledge Assessment (CKA)
Questions into Content Areas
Content Area
Fertility Awareness
General Contraceptive Knowledge
Short-acting Contraception Knowledge
Long-acting Reversible Contraception Knowledge
Other Contraceptive Methods Knowledge

CKA Questions in the Content Area
1, 2, 3
5, 6, 15, 18, 19, 21
8, 9, 10, 11, 12, 13, 14, 16, 17
20, 22, 23
4, 7, 24, 25

The “fertility awareness" category consists of three questions related to factors that
affect conception, such as when during a woman’s cycle is she most likely to get pregnant.
The “general contraceptive knowledge” category consists of six questions broadly related
to contraceptive method attributes such as which method of birth control is most effective.
The “short-acting reversible contraception knowledge” category consists of nine questions
about pills, patch, ring, and injections. The “long-acting reversible contraception
knowledge” category consists of three questions about IUDs and implants. The “other
contraceptive methods knowledge” category consists of four questions about male
condoms, withdrawal, or emergency contraception.
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Role of Family Planning Knowledge in Interventions
As described previously, there is a reliable association between family planning
knowledge and contraceptive use evident in at least two dozen studies. It has often been
assumed that this association is causal and as a result, one of the most common approaches
of efforts to change this and many other health behaviors has been education or
information-based approaches in which knowledge is provided to prompt individuals to
change their behavior (Bandura, 2004; Bettinghaus, 1986; Glanz, Rimer, & Viswanath,
2008; Marteau, Hollands, & Kelly, 2015; Michie, West, Campbell, Brown, & Gainforth,
2014; Rosenstock, Strecher, & Becker, 1988; Ryan, 2009). However, these interventions
have often not been effective. Specific to family planning, a recent systematic review of
the effect of contraceptive education on knowledge, contraceptive use, and incidence of
pregnancy underscores this disconnect. Pazol et al. (2018) identified 31 studies that tested
36 interventions that provided contraceptive education. Ninety percent of these studies
(28/31) reported a significant increase in knowledge after receipt of education about
contraception. However, among the nine studies that also examined the effect of
contraceptive education on a variety of measures of contraceptive use (e.g., contraceptive
initiation; correct, consistent, or continued use of contraception), only five reported
significant improvements in contraceptive use. The one study that examined incidence of
pregnancy reported a positive effect of the intervention on decreasing rates of pregnancy
at the time of follow-up, although this result was only marginally significant.
While it now appears overly simplistic to believe that increasing knowledge alone
will lead directly and reliably to healthier behavior, there is little question that knowledge
has a role in healthier behaviors. As the Centers for Disease Control and Prevention
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recently stated, “What people know and what they do with what they know has a major
impact on their life chances.” (Centers for Disease Control and Prevention, 2016). As a
result, many major theories of and approaches to changing health behavior include
knowledge, implicitly or explicitly, in one or more components of these models.
Behavioral economics. As noted previously, we are interested in the application
of behavioral economics theory to contraceptive use among women receiving OAT who
are at risk of unintended pregnancy. The field of behavioral economics, which began in
the 1990s, integrates psychological science with economic principles and has identified a
number of cognitive biases that often lead people to make health and other decisions that
are not consistent with their stated health goals. Ashton et al. (2015) recently published a
framework for applying behavioral economics to reproductive health outcomes. The
framework groups many of the cognitive biases identified by behavioral economics under
four sets of competing forces that each exist on a continuum (Table 2).
Table 2. Behavioral Factors That Influence Decision Making About
Reproductive Health
Illusion  Reality

Thinking Fast 
Thinking Slow

Today  Tomorrow

Self  Other

• Beliefs about facts

• Mental shortcuts

• Present bias

• Persuasion

• Beliefs about probability

• Limited attention

• Emotions, visceral drives

• Social norms, pressure

• Beliefs about preferences

• Intuition

• Sensation seeking

• Perceptions of social norms
• Altruism, reciprocal fairness
• Identity

Note. Adapted from “A review of behavioral economics in reproductive health,” by L. Ashton et al.,
2015, UC Berkeley: Center for Effective Global Action White Papers, 44, pp.16-25.

While knowledge about family planning per se is not an explicit part of the
framework, it is easy to see how knowledge plays a role in a number of biases in the
framework. For example, Illusion  Reality: Beliefs about probability may apply to
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assessments about fertility and pregnancy risk. As previously discussed, many women,
including women receiving OAT, assess their risk of pregnancy based on menstrual cycle
functioning (i.e. fertility awareness) and inaccurately assume menstrual cycle irregularities
reduce their fertility and subsequent risk of pregnancy. These inaccurate beliefs about the
low perceived probability of getting pregnant may increase pregnancy risk and contribute
to low rates of contraceptive use. Consequently, increasing fertility awareness may
contribute to decreasing the risk of unintended pregnancy by helping women and couples
more accurately assess the probability of getting pregnant and may promote increased use
of contraception during the “fertile window.”
The Thinking Fast  Thinking Slow: Mental shortcuts continuum also implicitly
addresses how people use knowledge and information to make decisions. Mental shortcuts
refer to rules of thumb that individuals utilize to make decisions (Tversky & Kahneman,
1974). These shortcuts, sometimes referred to as heuristics, are useful because they make
the complex task of assessing decisions in terms of probability, benefits/risk, and outcomes
manageable by creating a mental shortcut. However, heuristics based on inaccurate
information could lead to less optimal decisions. For example, as noted previously, the
majority of emergency contraception pills currently available are effective if women use
them within 72 hours of unprotected intercourse. However, if an individual has developed
a heuristic for emergency contraception pills that includes the “morning after pill”
colloquialism, she/he may limit use of this method to the first 24 hours after unprotected
intercourse, even though it would still be effective for 72 hours. There is research that
suggests individuals in the general population are misinformed about emergency
contraception, although to our knowledge there is no data available regarding individuals
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receiving OAT. In a study of young adults in the general population, 80% of participants
were aware of the emergency contraception pill, but only 44% correctly reported that this
method can be typically be used up to three days after unprotected intercourse (Yen,
Parmar, Lin, & Ammerman, 2015), suggesting many are not maximizing the use of
emergency contraception pills to decrease the risk of an unintended pregnancy.
Consequently, increasing knowledge about family planning methods may decrease the risk
of unintended pregnancy by modifying mental short cuts individuals rely on to inform their
contraceptive behavior.
Another example is found in the Today  Tomorrow: Present bias continuum.
Present bias is the tendency to over-value immediate rewards at the expense of long-term
intentions. Applied to contraceptive behavior, individuals may be more likely to choose
not to use contraception, which does not have any upfront costs in terms of money, time,
Table 3. Present Bias as it Applies to Different Types of Contraception
No
Contraception
Condoms

Prescription
Contraception

Initiation Costs/Efforts
• No planning ahead
• No cost
• Available over the counter
at various locations
• Relatively inexpensive
• Visit with a qualified
healthcare provider
• Relatively expensive
prescription (pills, patch,
ring) and somewhat
uncomfortable procedure
(injection, IUD, implant)

Continuation Costs/Efforts
• No planning ahead
• No cost

Gains
• 85% chance of
pregnancy

• Remember to use method

• 13% chance of
pregnancy

• Tolerate bothersome, but
rarely, medically serious,
side effects
• Remember to use method
(pills, patch, ring, injection)

• Average 3%
chance of
pregnancy

or effort (Table 3, top row), instead of going through the costly process of obtaining
contraception, with the more effective methods requiring additional upfront costs (Table
3, bottom row). While everyone has this bias to some degree or another, calculation of the
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literal and figurative costs will be influenced by an individual’s knowledge. For example,
as Table 3 indicates, continuation costs for the more effective methods (i.e. prescription
contraceptives) include tolerating bothersome but rarely medically serious side effects. If
an individual mistakenly believes that IUDs can cause infections that lead to infertility,
she/he is likely to inaccurately assess the figurative costs of that method, thereby
decreasing the likelihood of choosing this highly effective methods. We recently asked
women receiving OAT who reported they were unlikely to use an IUD why they were
unlikely to choose this method; nearly half (45%) reported it was because they were
concerned about getting an infection (Matusiewicz et al., 2017). This misperception may
be adversely impacting calculation of the costs of IUDs despite their near-perfect rate of
effectively preventing pregnancy. Therefore, increasing knowledge about contraception
may contribute to decreasing the risk of unintended pregnancy by modifying the value
individuals place on the immediate versus long-term costs and benefits of using
contraception.
Other theoretical models. While we approach the issue of contraceptive decisionmaking among women and men receiving OAT from a behavioral economics perspective,
there are of course other theoretical models that address health behaviors like contraceptive
decision-making. A recent review by Lopez et al. (2016) reported on 25 theory-based
interventions for contraception. The authors grouped interventions by theory and found
that the majority of the studies reviewed were based on one of two theories or approaches.
Most common was a social cognitive approach like the Health Belief Model (HBM). Social
cognitive approaches suggest that decisions about health behavior are made deliberately
by weighing the perceived costs and benefits of engaging in a particular behavior.
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Consequently, changes
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of Pregnancy
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Action

Perceived Seriousness
and Susceptibility:
- Pregnancy
knowledge
- Pregnancy beliefs

Internal:
- Missed menses
External:
- Provider
counseling

Contraceptive
Cost-Benefit
Analysis
Perceived Benefits:
- Knowledge of
efficacy
- Beliefs about
efficacy
- Method feasibility
- Initiation method
Perceived Barriers:
- Perceived side
effects
- Perceived risks
Cost

in behavior are achieved
by

targeting

components

of

interaction

between

the

individuals,

their

environment

and

behavior (Glanz et al.,
Modifying and Enabling Factors and Examples of Each
Demographics: Age, race, education
Reproductive: Prior contraceptive use, prior unwanted pregnancy
Psychological: Forgetfulness, emotional wellbeing
Social: Partner status, domestic abuse
Structural: Health insurance, lack of daily routine

2008; Rosenstock et al.,
1988; Sallis & Owen,
2015).
grouping

The

second
of

Contraceptive Decision Making

interventions combined
Likelihood of a Contraceptive Behavior

Figure 3. Contraceptive Behavior Health Belief Model.
Adapted from “The Health Belief Model can guide modern
contraceptive behavior research and practice,” by K. Hall,
2012, Journal of Midwifery & Women’s Health, 57(1), 79.

those

using
Motivational

Interviewing (MI) with
those that were rooted in

the Information-Motivation-Behavior Skills (IMB) Model. MI also presumes changes in
health behavior are defined by an assessment of the costs and benefits associated with
engaging in a particular behavior (Prochaska & DiClemente, 1982, 1986). As a clinical
technique, the goal of MI is for providers to engage their patients, elicit change talk, and
evoke patient motivation to support positive behavioral changes. The IMB Model suggests
that information and motivation influence health behavior change by activating skills
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necessary to reduce risky behaviors and maintain behavioral change (Fisher & Fisher,
1992).
While all three of these approaches have somewhat different perspectives,
knowledge is included in components of all three frameworks. In a revised version of the
HBM that focused on contraception (Hall, 2012), pregnancy knowledge and knowledge of
the
Risk reduction
information

Risk reduction
motivation

efficacy

contraceptives

of
are

included in two different
components (Figure 3,
Risk reduction
behavioral skills

upper

left

and

right

boxes). In MI, one of the
primary

motivational

Prevention behavior

techniques
Figure 4. Information-Motivation-Behavioral Skills
Model. Adapted from “Changing AIDS-risk behavior,”
by J. Fisher, 1992, Psychological Bulletin, III(3), p.465.

is

“Advice/Feedback”,
wherein

practitioners

use neutral and nonjudgmental questions (e.g., “Are you interested in learning more about …?” or “What do
you know about the benefits of …?”) to introduce factual information into sessions or
correct misinformation in an effort to help patients identify advantages and disadvantages
of initiating a specific health behavior (Rollnick, Butler, Kinnersley, Gregory, & Mash,
2010; Sobell & Sobell, 2013). Finally, as the title and description of the IMB model
indicates, information (or knowledge) about risk reduction is an explicit component of this
model (Figure 4; Boyer et al., 2005; Fisher & Fisher, 1992).
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Summary
Consistently low rates of contraceptive use and high rates of unintended pregnancy
suggests an unmet need for effective contraceptive use among women and men receiving
OAT. As described earlier, there is a reliable, but rarely causal, relationship between family
planning knowledge and contraceptive behavior. The complexity of the theoretical models
reviewed suggests that knowledge plays a role in behavior, although on its own, knowledge
will seldom be sufficient to elicit substantial behavior change. There are limited data about
family planning knowledge among women and men receiving OAT, which has
implications for how best to proceed with efforts to increase contraceptive use and reduce
unintended pregnancy in this population. If there is a deficit in family planning knowledge,
the literature reviewed earlier suggests that increasing knowledge alone is unlikely to cause
substantive behavior change. However, as one example, the HBM suggests that accurate
knowledge of pregnancy risk and contraceptive efficacy, when combined with other
components of the model like effective provider counseling, could lead to significant
changes in behavior. As another example, an MI approach suggests that clinical feedback
that includes accurate information about contraceptive method side effects, when combined
with MI techniques like open-ended questions that assess patient responses to the
information and efforts to elicit change talk, could lead to significant changes in behavior.
If there is not a substantive deficit in family planning knowledge, then interventions should
focus on additional factors that influence behavior. For example, behavioral economics
might suggest an intervention that reduces literal and figurative costs of accessing
contraception, while interventions based on the HBM might focus on the quality of the
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patient-provider relationship and explore how the health care provider might influence
contraceptive decision-making (e.g. cues to actions). Thus, characterizing family planning
knowledge among women and men receiving OAT will help provide direction to efforts to
increase contraceptive use and decrease unintended pregnancy in this high-risk population.
The aims of this study were:
Aim 1 (Primary). Examine family planning knowledge among women and men
receiving OAT as compared to women and men receiving PC services. The latter sample
was selected as the comparison group because these individuals are also receiving an
outpatient medical service and can serve as a proxy for the general population.
Hypothesis 1a. Consistent with observations of low rates of contraceptive use and
high rates of unintended pregnancy among individuals receiving OAT, the mean percent
of correct responses on the CKA will be lower (i.e. less knowledge about family planning)
among the OAT sample compared to the PC sample.
Hypothesis 1b. Consistent with the tendency for society to see pregnancy
prevention and contraceptive use as primarily women’s issues, women in both samples (i.e.
receiving OAT or PC) will have a higher mean percent of correct responses on the CKA
(i.e. more family planning knowledge) than men.
Aim 2 (Exploratory). Evaluate specific content areas of family planning
knowledge among women and men receiving OAT compared to women and men receiving
PC. We will compare the mean percent of correct responses on the CKA in the areas of 1)
fertility awareness, 2) general contraceptive knowledge, and knowledge of 3) short-acting
contraception, 4) long-acting reversible contraception, and 5) other contraceptive methods
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between patient samples and between sexes but are not proposing specific hypotheses for
these outcomes.
Aim 3 (Exploratory). Examine the potential interaction of patient sample and sex
on family planning knowledge. If main effects of patient sample and sex are significant
for the mean percent of correct responses on the CKA and/or among the five content areas
(i.e. fertility awareness, general contraceptive knowledge and knowledge of short-acting,
long-acting, and other contraceptive methods) we will look at their interaction, but are not
proposing specific hypotheses for these outcomes.
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Method

Patient Samples and Settings
Patients receiving OAT. A cross-sectional survey of women and men receiving
OAT was conducted. Research staff recruited patients receiving either methadone or
buprenorphine from the Chittenden Clinic, a large (~1,000 patients), outpatient treatment
facility in Burlington, VT. Due to federal regulations, this OAT facility cannot treat
individuals less than 18 years old, so all patients were at least 18 years old. All women and
men receiving OAT were eligible to participate in this study, although final analysis was
restricted to women and men of reproductive age (18-45 years old) because family planning
is most relevant to this age group.
Family planning services are very limited in this setting. According to Chittenden
Clinic protocol, both women and men are asked about current contraceptive use at intake
and women are administered pregnancy tests once a month during treatment. A positive
urine pregnancy test results in a referral to a University of Vermont Medical Center
(UVMMC) obstetrics practice that manages pregnant women receiving OAT. Women may
also receive additional reproductive health referrals (e.g. gynecological care). Male
condoms are available free of charge to all patients onsite at the Chittenden Clinic. No
other family planning services are provided.
Patients receiving PC. For comparison, a cross-sectional survey of women and
men receiving PC from two UVMMC-affiliated practices in Burlington, VT was
conducted. Research staff recruited patients from UVMMC Adult Primary Care and
Appletree Bay Primary Care; all reproductive-age women and men (18-45 years old) were
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eligible to participate. To be consistent with the OAT sample, patients less than 18 years
old were not eligible to participate. Patients in these practices receive a wide range of health
care services related to health promotion, disease prevention, diagnosis and treatment of
acute and chronic illnesses, and education and counseling about various health issues.
Family planning services can be integrated into primary care, although the breadth and
depth of such services vary by provider. Women and men are typically asked about their
current contraceptive use at annual exams and may be provided sexual and reproductive
health counseling where indicated. A positive pregnancy test results in a referral to a local
obstetrics practice.
All practice administrators (i.e. Chittenden Clinic, UVMMC Primary Care and
Appletree Bay Primary Care) approved all study procedures. The Institutional Review
Board of the University of Vermont also approved this study.

Measures
Family planning knowledge was measured with the previously-described
Contraceptive Knowledge Assessment (CKA; Appendix). All 25 questions are multiple
choice, with five answer choices, except for one question (Question 21) that has six
possible responses. “I don’t know” is the final possible answer for all 25 questions.
Consistent with the recommendations of others (Trussell, 2017), we modified the wording
of one of the responses for three different CKA questions to be more accurate. First, on
Question 4, we changed “semen” to “sperm” because pre-ejaculate does not contain semen
(Killick, Leary, Trussell, & Guthrie, 2011). Second, on Question 10, we changed the
response “one month” to “three months” because the vaginal ring can technically be used
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continuously for one month, with no hormone-free days (Zieman, Hatcher, Allen, Lathrop,
& Haddad, 2016). Third, on Question 24, we replaced the response “five days” with “three
days” to reflect U.S. Food & Drug Administration packaging on levonorgestrel emergency
contraception (U.S. Food & Drug Administration, 2016). We also changed “doctor” to
“provider” on Questions 20 and 23 to be more inclusive of all health care providers.

Procedures
Study recruitment occurred in designated areas of the OAT and PC office waiting
rooms at various times throughout a given week (3-4 hours a day, 2-3 times per week).
Interested patients had the opportunity to discuss study participation with research staff
either before or after their appointments. Participants were asked to provide very basic
demographic information and then completed a paper copy of the CKA. The average time
to complete the questionnaire was approximately 10 minutes; total study participation time
was less than 15 minutes. Upon completion of the CKA, participants were offered a copy
of the correct answers to take home. Participants were compensated with a $20 gift card
for their time.

Analysis
The percentage of correct responses for all CKA questions for each participant was
calculated. Primary and exploratory hypotheses were tested using two-way analysis of
variance (ANOVA) with fixed factors, patient sample (i.e. receiving OAT or PC) and sex
(i.e. female or male) along with their interaction. Analyses of the five content areas (i.e.
fertility awareness, general contraceptive knowledge, and knowledge about short-acting,
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long-acting, or other contraceptive methods) paralleled those conducted to calculate the
percentage of correct responses for all CKA questions. The normality and homogeneity of
variance assumptions associated with two-way ANOVAs were examined based on normal
probability plots of residuals and Levene’s test, respectively. Participant age was examined
as a potential covariate because there was a significant difference in age between the OAT
and PC patients samples and between women and men. Unadjusted values for mean percent
correct are presented for the total CKA score and the five content areas because controlling
for age did not have a significant effect on results.
A sample size of 320 participants (n=80/group) was estimated to have power (1) = .80 using α=.05 to detect an effect size (Cohen’s d) = 0.28 for main effects of patient
sample and sex on our primary outcome of total correct responses on the CKA. This effect
size represents a small to medium effect size. This power and estimated effect size also
applies to analyses of the five content areas of family planning knowledge.
Analyses were conducted using StataSE version 15 (Stata Statistical Software:
Release 15. College Station, TX: StataCorp LLC) and SAS statistical software version 9.4
(SAS Institute, Cary, NC). Statistical significance was determined based on α=.05.
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Results

Sample Characteristics
Overall, 332 participants completed this survey. There was a total of 167 patients
receiving OAT (women: n=85, men: n=82) and 165 patients receiving PC (women: n=84,
men: n=81; Table 4). Overall, the mean age of participants was 32.1 years. On average,
patients receiving OAT were significantly older compared to PC patients, 32.9 vs. 31.3
years, respectively, F(1,328) = 6.02 p<.05. On average, females were significantly younger
compared to males, 31.2 vs. 33.0 years, respectively, F(1,328) = 6.87 p<.01. There was no
significant interaction effect between patient sample and sex for age, F(1,328) = 0.02,
p< .89. The overwhelming majority of participants were white (86%) and there were no
differences by patient sample or sex.

CKA Responses
CKA total. Overall, the mean percent of correct responses on the 25 CKA
questions was 50% (mean=12.5), with a range of 4% to 88%. On average, patients
receiving OAT answered 47% (mean=11.8) of the 25 CKA questions correctly compared
to 53% (mean=13.3) for patients receiving PC (Figure 5, top left panel). Simple main
effects analysis of patient sample showed patients receiving OAT had a significantly lower
mean percentage of correct responses compared to patients receiving PC, F(1,328) = 11.6
p<.001. On average, women answered 56% (mean=13.9) of the 25 CKA questions
correctly compared to 44% (mean=11.1) for men (Figure 5, top right panel). Simple main
effects analysis of sex showed that women had a significantly higher mean percentage of
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correct responses than men, F(1,328) = 38.47, p< .0001. The interaction effect between
patient sample and sex was not significant, F(1,328) = 0.12, p=.73 (Figure 5, bottom panel).
CKA content areas.
Fertility awareness. Overall, the mean percent of correct responses on the three
fertility awareness questions was 53% (mean=1.6; Table 5). On average, patients
receiving OAT answered 49% (mean=1.5) of the three questions correctly compared to
58% (mean=1.7) for patients receiving PC. Simple main effects analysis of patient
sample showed that patients receiving OAT knew significantly less about fertility
awareness compared to patients receiving PC, F(1,327) = 10.33, p<.01. On average,
women answered 58% (mean=1.7) of the three questions correctly compared to 48%
(mean=1.5) for men. Simple main effects analysis of sex showed that women knew
significantly more about fertility awareness than men, F(1,327) = 10.90, p<.01. The
interaction effect between patient sample and sex was not significant, F(1,327) = 0.00,
p=.97.
General contraceptive knowledge. Overall, the mean percent of correct responses
on the six questions about general contraceptive knowledge was 66% (mean=4.0; Table 5).
On average, patients receiving OAT answered 62% (mean=3.7) of the six questions
correctly compared to 70% (mean=4.2) for patients receiving PC. Simple main effects
analysis of patient sample showed that patients receiving OAT knew significantly less
about general family planning compared to patients receiving PC, F(1,327) = 11.47,
p<.001. On average, women answered 70% (mean=4.2) of the six general contraceptive
knowledge questions correctly compared to 62% (mean=3.7) for men. Simple main effects
analysis of sex showed that women knew significantly more about general family planning
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compared to men, F(1,327) = 7.92, p<.01. The interaction effect between patient sample
and sex was not significant, F(1,327) = 1.42, p=.23.
Short-acting contraception knowledge. Overall, the mean percent of correct
responses on the nine questions about short-acting contraception (i.e. pills, patch, ring, and
injectables) knowledge was 37% (mean=3.4; Table 5). On average, patients receiving OAT
answered 37% (mean=3.3) of these nine questions correctly, similar to 38% (mean=3.4)
for patients receiving PC. There was no significant difference in knowledge about shortacting contraception between the patient samples, F(1,327) = 0.14, p=.66. On average,
women answered 45% (mean=4.0) of the nine questions about short-acting contraception
correctly compared to 30% (mean=2.7) for men. Simple main effects analysis of sex
showed that women knew significantly more about short-acting contraception compared
to men, F(1,327) = 45.00, p<.001. The interaction effect between patient sample and sex
was not significant, F(1,327) = 0.50, p=.48.
Long-acting reversible contraception knowledge. Overall, the mean percent of
correct responses on the three questions about long-acting reversible contraception (i.e.
implants and IUDs) knowledge was 43% (mean=1.3; Table 5). On average, patients
receiving OAT answered 38% (mean=1.1) of the three questions correctly compared to
48% (mean=1.4) for patients receiving PC. Simple main effects analysis of patient sample
showed that patients receiving OAT knew significantly less about long-acting
contraception compared to patients receiving PC, F(1,327) = 9.20, p<.01. On average,
women answered 53% (mean=1.6) of the three questions correctly compared to 33%
(mean=1.0) for men. Simple main effects analysis of sex showed that women knew
significantly more about long-acting reversible contraception compared to men, F(1,327)
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= 39.71, p<.001. The interaction effect between patient sample and sex was not significant,
F(1,327) = 0.51, p=.47.
Other contraceptive methods knowledge. Overall, the mean percent of correct
responses on the four questions about other contraceptive methods (i.e. withdrawal,
condoms, and emergency contraception) knowledge was 58% (mean=2.3; Table 5). On
average, patients receiving OAT answered 53% (mean=2.1) of these four questions
correctly compared to 62% (mean=2.5) for patients receiving PC. Simple main effects
analysis of patient sample showed that patients receiving OAT had significantly less
knowledge about other methods compared to patients receiving PC, F(1,327) = 9.99, p<.01.
On average, women answered 59% (mean=2.4) of the four questions about other
contraceptive methods correctly compared to 56% (mean=2.2) for men. There was no
significant difference in knowledge of other methods between women and men, F(1,327)
= 1.17, p=.28. The interaction effect between patient sample and sex was also not
significant, F(1,327) = 0.14, p=.71.
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Discussion

To continue efforts to understand why rates of unintended pregnancy are
approximately two-fold higher among women receiving OAT than women in the general
population, this study compared knowledge about family planning among women and men
receiving OAT to a sample of women and men receiving PC. Overall, our findings indicate
that there are significant effects of both patient sample (i.e. OAT vs. PC) and sex (i.e.
females vs. males) on the total score on the CKA as well as most of the content areas.
Differences in family planning knowledge (or lack thereof) as a function of patient sample
will be discussed first, followed by those as a function of sex.
Patient Sample
Total score. The mean percent of correct responses on the CKA among individuals
receiving OAT was approximately 10% lower than individuals receiving PC. However,
patients in both samples answered only approximately 50% of the CKA questions
correctly, indicating significant gaps in family planning knowledge for all participants.
While the difference between patient samples was statistically significant, it is less clear
how clinically important a difference of around 5%, or 1.5 questions, is. Given that the
rate of unintended pregnancy among women receiving OAT is almost double that of the
general population (Black et al., 2012; Finer & Zolna, 2016; Fischbein et al., 2018;
Kreitinger et al., 2016; Meschke et al., 2018; Smith et al., 2019; Welle-Strand et al., 2015),
it is somewhat surprising that individuals receiving OAT did not have substantially lower
levels of family planning knowledge.

The theoretical approaches described in the

Introduction make clear that no one factor explains contraceptive behavior: rather,
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decisions about contraceptive behavior are the compound result of a multitude of factors.
The present results suggest that deficits in knowledge, by themselves, are likely only
playing a small role in the large discrepancy in rates of contraceptive use and unintended
pregnancy among women receiving OAT and women in the general population, although
improving knowledge in combination with other approaches may have a larger effect.
Interestingly, the mean percent of correct responses on the CKA for both patient
samples was at least 25% higher than the patient sample reported by Haynes et al. (2017)
in the original report on the CKA. These differences may be a function of characteristics
of their patient sample, which they described as an ethnically diverse group of medically
underserved and underinsured patients, 15 to 45 years old, attending an urban ambulatory
care center. Research consistently demonstrates ethnic and racial disparities in
contraceptive knowledge, effective use of contraception, and pregnancy intention in the
general population (Borrero, Farkas, Dehlendorf, & Rocca, 2013; Craig, Dehlendorf,
Borrero, Harper, & Rocca, 2014; Finer & Zolna, 2016; Grady, Dehlendorf, Cohen, Bimla
Schwarz, & Borrero, 2015; Rosenfeld et al., 2017; Stidham Hall et al., 2016). These
disparities appear to be driven by psychosocial and economic differences, such as age, US
nativity, education, and income (Dehlendorf et al., 2014; C. D. Grady et al., 2015; Jackson,
Wang, & Morse, 2017; Kim, Dagher, & Chen, 2016). While neither the Haynes et al. study
nor the present study collected more than basic demographic information from participants,
a possible difference in age and likely differences in US nativity between these samples
may have contributed to the higher mean percent of correct responses in the present study
compared to the Haynes et al. sample.
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With regard to age, the Haynes et al. study team purposefully included adolescents
ages 15 to 17 in their eligible age range because this age group has a high risk of unintended
pregnancy (72%; Finer & Zolna, 2016). While we agree with this rationale, federal
regulations require that patients who receive OAT from adult, outpatient treatment
facilities must be at least 18 years old; thus, the Chittenden Clinic population does not
represent the full reproductive age range. Adolescents may have less knowledge about
family planning because they have had less time to be exposed to this information in school,
at home, and in other settings. It is unclear what percentage of the Haynes et al. sample is
adolescents; if the proportion was substantial, this may have contributed to the overall
lower scores of that sample.
With regard to US nativity, conversations with the Haynes et al. study team
revealed that they recruited all of their participants from Bellevue Hospital in New York
City, NY, whose patient population is estimated to have a high rate of foreign-born patients
(personal communication, 7/13/2018). By contrast, the overwhelming majority of Vermont
residents are non-Hispanic and only 5% of the population is foreign-born (US Census
Bureau, 2018), making it very likely that there were few patients in either the OAT or PC
samples in the present study that were not born in the US. Foreign-born women living in
the US are less likely to have access to healthcare compared to US-born women which has
been shown to contribute to lower rates of family planning service utilization, thereby
decreasing opportunities to receive education and counseling about contraception (Tapales,
Douglas-Hall, & Whitehead, 2018). This may in turn have contributed to lower levels of
knowledge in the Haynes et al. sample.
CKA content areas.
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Fertility awareness. Examination of CKA questions by specific content provides
useful information about the similarities and differences in five areas of family planning
knowledge between these two patient samples. The percent of correct responses about
fertility awareness was approximately 16% lower among individuals receiving OAT
compared to the individuals receiving PC. As discussed in the Introduction, cognitive
biases such as inaccurate beliefs about the perceived probability of a health risk can
contribute to less optimal decision-making about health. Consistent with this, studies have
shown that poor fertility awareness contributes to an increased likelihood that
women/couples will incorrectly assess their risk of pregnancy (Lundsberg et al., 2014) and
a decreased likelihood of contraceptive use (Mosher et al., 2015; Nettleman et al., 2007).
Poor fertility awareness may be exacerbated among individuals receiving OAT because
women receiving OAT report high rates of menstrual irregularities (Dürsteler-MacFarland
et al., 2010; Haber et al., 2017; Santen, Sofsky, Bilic, & Lippert, 1975; Schmittner,
Schroeder, Epstein, & Preston, 2005). In the largest and most detailed study of menstrual
cycle function among women receiving OAT, only 28% of more than 100 women had
regular menstrual cycles, defined as 20-40 days in length (Schmittner et al., 2005).
Menstrual irregularities make it more difficult to predict fertility status (i.e. when a woman
is most likely to become pregnant) and may contribute to misperceptions about the
probability of becoming pregnant. Inaccurate assessments about pregnancy risk may in turn
interfere with effective use of contraception, thereby increasing the risk of unintended
pregnancy.
Given the increased frequency of cycle-length irregularities among women
receiving OAT, there is a greater likelihood of incorrectly identifying a woman’s fertile
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window.

Incorporating information about fertility awareness into family planning

interventions for individuals receiving OAT, with an emphasis on the potential side effects
of agonist medication and other substance use on menstruation, may contribute to
decreasing the risk of unintended pregnancy by clarifying that menstrual irregularities are
not synonymous with infertility, thereby helping women/couples to more accurately assess
pregnancy risk.
General contraceptive knowledge. There was a significant difference in general
knowledge about contraception between patient samples: patients receiving OAT scored
approximately 10% lower than patients receiving PC. However, patients in both samples
answered two thirds of these questions correctly, suggesting that both groups are fairly
well-informed with regard to general information regarding contraception. Given this,
efforts to improve contraceptive knowledge may be more impactful if they target the larger
knowledge deficits in fertility awareness and method-specific content areas (i.e. short- and
long-acting contraception, and other contraceptive methods) rather than allocating
resources to improve general knowledge about contraception.
Short-acting contraception knowledge. Although there were no differences in
knowledge about short-acting contraception between patient samples, the overall low level
of knowledge about short-acting methods is clinically concerning and may help explain
why there is a 7% discrepancy in the rate of pregnancy between perfect use and typical use
of pills, the most commonly used short-acting contraceptive method among women in the
general population (Kavanaugh & Jerman, 2018; Trussell et al., 2018). In addition, the user
demands associated with short-acting methods (e.g. remembering to take a pill every day),
may increase user error which contributes to increased risk of pregnancy overall.
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Therefore, incorporating information about mechanisms of action and attributes of shortacting methods into family planning interventions may increase knowledge about these
methods and promote more effective use.
Long-acting reversible contraception knowledge. Examination of the long-acting
reversible contraception knowledge content area identified there was a significant
difference in LARC knowledge between patient samples. Individuals receiving OAT
scored approximately 20% lower than individuals receiving PC in this content area. This
discrepancy is somewhat surprising given the similarities in the estimated prevalence of
current LARC use among women receiving OAT and the general population (18% and
14%, respectively). If women receiving OAT are managing to use LARCs at a rate similar
to the general population despite significant deficits in knowledge about these methods,
one strategy to increase LARC use among women receiving OAT is to promote greater
knowledge about LARC attributes, efficacy, and use among this population in an effort to
further increase rates of LARC use. In fact, a recent study by Kotha et al. (2019) reported
that increasing knowledge about LARCs via contraceptive counseling increased intention
to use LARCs postpartum among a large sample of pregnant women receiving OAT.
Although there are of course discrepancies between LARC intent and subsequent use
(Ogburn et al., 2005; Engin-Ustun et al., 2007; Chen et al., 2010; Kotha et al., 2019),
increasing knowledge about LARCs is a first step in promoting their use and should be
incorporated into family planning interventions in general and may be particularly
influential in increasing uptake among women receiving OAT.
Other contraceptive methods knowledge. There was a significant difference
between patient samples in the percent of correct responses on questions in this content
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area (i.e. knowledge about the withdrawal method, male condoms, and emergency
contraception pills). Patients receiving OAT only answered approximately half of these
questions correctly, about 15% less than patients receiving PC. This has implications
clinically. For example, poor knowledge about emergency contraception pills may interfere
with correct use of this method. Given the overall low rates of contraceptive use among
individuals receiving OAT (Black et al., 2012; Cornford et al., 2015; Krans et al., 2018),
use of emergency contraception provides a unique opportunity to prevent pregnancy after
unprotected intercourse (Trussell et al., 2018). As discussed in the Introduction, the
colloquial name for emergency contraception, “morning after pill,” may be misleading,
thereby interfering with optimal use. Misperceptions about the use of emergency
contraception pills may arise from inaccurate portrayals by various sources, including the
media and pharmacists, about how emergency contraception pills work and/or their
availability (Moore, Ryan, & Stamm, 2018; Nelson & Jaime, 2009; Pruitt & Mullen, 2005).
Consequently, increasing individual knowledge about emergency contraception pills may
decrease risk of unintended pregnancy by modifying mental short cuts (i.e. heuristics) or
misinformation individuals reference to inform their contraceptive behavior.

Sex
In addition to differences between patient samples in the percent of correct
responses overall and among most of the CKA content areas, the percent of correct
responses overall and among four of the five CKA content areas also differed by sex. With
the exception of the “other contraceptive methods knowledge” content area, women
demonstrate more knowledge about family planning than men. Given that family planning
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has historically been focused on women and the majority of contraceptive methods
available are for use by women, these results were not unexpected. Historically, family
planning services were focused on the needs of women and failed to incorporate education
and interventions for men. However, beginning in the mid-1990s, there was an
international effort by family planning and reproductive health organizations to provide a
framework for addressing men’s unique reproductive needs and inclusion in family
planning services (Bustamante-Forest & Giarratano, 2004; Cornwall & White, 2000;
Drennan, 1998; Sternberg & Hubley, 2004). There is evidence that these efforts are starting
to have some impact. For example, the federal Office of Population Affairs and the CDC
recommend “women and men of childbearing age should have high reproductive
awareness (i.e. understand factors related to childbearing) and a reproductive life plan” and
receive family planning services (emphasis added; Gavin et al., 2014). To this end, more
recent research has demonstrated that male partners believe they should participate in
decision-making about contraception (Grady et al., 1996; Richards et al., 2016; Stewart et
al., 2017). Therefore, one strategy to optimize reproductive awareness for men is to
increase knowledge about ways to prevent unintended pregnancy in general (e.g.
knowledge about effective use of contraception and fertility awareness) and not just focus
on contraceptive methods available for men.
The revised Health Belief Model proposed by Hall et al. (2012) is the only model
to our knowledge that explicitly includes men as a modifying/enabling factor that can
influence decisions about contraceptive use. In fact, there is some research that suggests
among women receiving OAT, a woman’s familiarity with her partner is an important
factor in whether or not she uses contraception (Fischbein et al., 2018). Given that the
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majority of men in the US are in need of family planning services (Marcell et al., 2016),
increasing men’s individual knowledge about contraception and fertility awareness may be
an important preliminary step to increase contraceptive use and decrease rates of
unintended pregnancy.

Comparison to Existing Literature
It was noted in the Introduction that methodological differences made it difficult to
directly compare the results of the two published quantitative studies of which we are aware
on contraceptive knowledge among women receiving OAT to each other (Matusiewicz et
al., 2017; Meschke et al., 2018). Unfortunately, methodological differences also limit
comparisons between the present results and these two studies.

More specifically,

differences in sample population (i.e. a convenience sample of women receiving OAT in
the present study and the Meschke et al., 2018 study compared to a more restricted sample
in the Matusiewicz et al., 2017 study), question response format (i.e. five response choices
vs. true/false), question content, and presentation of results (i.e. overall knowledge vs.
information about specific content areas), make specific comparisons and contrasts
exceedingly difficult and are likely not very meaningful. However, it can be said that the
three studies overall provide consistent evidence of generally moderate levels of
knowledge about family planning among women receiving OAT.

Study Limitations
There are some limitations of this study. First, prior contraceptive use and other
demographic, sexual, and family planning characteristics were not examined. Although
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participant age was examined as a potential covariate and found not to play a role, it is
unclear if there are other confounding factors associated with patient sample or sex that
may be influencing family planning knowledge. Thus, future research should examine
whether these characteristics impact family planning knowledge and behavior. Second, this
study was not powered to analyze individual items on the CKA. Given the relatively high
levels of general knowledge about contraception and low levels of knowledge about
different types of contraception, additional research is necessary to identify the specific
knowledge deficits of different contraceptive methods. Third, although the five CKA
content areas were established by expert review, no psychometric evaluation of these areas
was conducted. Additional analyses (e.g. factor analysis, inter-item correlations) are
necessary to confirm the construct validity of the content areas to further expand the utility
of this measure. Finally, it is unclear how generalizable these results are to other
populations of individuals diagnosed with OUD. Within-group studies are necessary to
identify family planning knowledge and contraceptive use among different groups of
individuals with OUD. For example, is family planning knowledge similar among various
groups of individuals with OUD, or are differences in age, education, treatment status, or
geographic location associated with different levels of family planning knowledge?
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Conclusion

Contraceptive use is low (~50%) and unintended pregnancy rates are high (~80%)
among women receiving OAT. In the absence of basic knowledge about family planning
it is unreasonable to expect effective use of contraception. The results of this study
indicate that there are statistically significant differences in family planning knowledge
between individuals receiving OAT and a comparison sample, but the absolute
differences were generally small. Therefore, in settings where resources are limited,
providing women and men receiving OAT with accurate information about family
planning may lead to small increases in effective use of contraception and small
decreases in unintended pregnancy. However, to make significant gains in this area,
interventions will have to include additional components.
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Appendix

Contraceptive Knowledge Assessment (CKA)
1. When during a woman’s cycle is she most likely to
become
pregnant?
a. During her period (start of her cycle)
b. 3 days after her period ends
c. Two weeks before her next period starts
d. 3 days before she gets her period (end of cycle)
e. I don’t know

7.

2. How long can sperm stay alive in a woman’s body?
a. 1-3 hours
b. 24 hours
c. 3-5 days
d. 7-10 days
e. I don’t know

8.

3. Which of the following choices is TRUE about
pregnancy?
a. You cannot become pregnant the first time you
have sex
b. You cannot become pregnant if you have sex
standing up
c. You cannot become pregnant if you do not have an
orgasm
d. None of the above are true
e. I don’t know
4. Which of the following choices is TRUE about
withdrawal, or the
“pull-out” method?
a. Sperm may be released before ejaculation
b. Withdrawal works as well as condoms at
preventing pregnancy
c. Withdrawal can protect against some sexually
transmitted diseases (STDs)
d. Withdrawal works as well as the birth control pill
at preventing pregnancy
e. I don’t know
5. Which birth control method guarantees you will not
become
pregnant?
a. None
b. Using a condom every time you have sex
c. Douching, showering, or bathing immediately after
sex
d. “Pulling out” before ejaculation
e. I don’t know
6. Which is the only birth control method that helps
prevent infections?
a. The birth control pill
b. Male and female condoms
c. Depo-Provera (“the shot”)
d. The IUD (intrauterine device, the “T”)
e. I don’t know
Note. Correct answers are in bold and italicized.

9.

All of the following are TRUE about using male
condoms EXCEPT:
a. You should use water-based lubricants with spermicide
b. Wear two condoms to be extra safe
c. Prevent air bubbles by holding the condom tip when
putting it on
d. Check the expiration date and keep them in a cool and
dry environment (i.e. not in a wallet or in a car)
e. I don’t know
Hormonal birth control comes in which of the
following forms?
a. Pills taken by mouth
b. Patch worn on the skin
c. Ring placed in the vagina
d. All of the above
e. I don’t know
Which one is NOT a benefit of hormonal birth control?
a. Improvement of diabetes
b. Improvement of acne
c.

Reduction in menstrual cramps and bleeding problems
like anemia
d. Decreased risk of ovarian and uterine cancer
e. I don’t know

10. How long should the vaginal ring (NuvaRing) stay in
place before changing it?
a. 1 day
b. 1 week
c. 3 weeks
d. 3 months
e.

I don’t know

11. Which of the following make hormonal birth control
less effective?
a.
b.
c.
d.
e.

Seizure (epilepsy) medicine
HIV medicine
Herbal supplements
All of the above
I don’t know

12. What is the main way that birth control works?
a. It prevents the ovary from releasing the egg (ovulation)
b. It prevents the sperm from entering the uterus
c. It prevents the fertilized egg from implanting in the
utuerus
d. It prevents the embryo from growing past a certain size
e. I don’t know
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13. Birth control pills can have which of the following ingredients?
a. Testosterone
b. Estrogen
c. Magnesium
d. Calcium
e. I don’t know

19. Which birth control method is not easily noticed by a
partner?
a. The IUD (intrauterine device)
b. The vaginal ring
c. Male condom
d. Female condom
e. I don’t know

14. You should NOT use the birth control pill if you have
any of the following:
a. Fibroids
b. Drink alcohol
c. Currently taking antibiotics
d. None: it is safe to use the birth control pill in all of
these situations
e. I don’t know
15. How long after a woman stops using birth control can
she become pregnant?
a. Immediately
b. 1 month
c. 3 months
d. 6 months
e. I don’t know

20. A provider places an IUD (intrauterine device) in
which part of the body?
a.
Fallopian tube
b.
Uterus
c.
Cervix
d.
Vagina
e.
I don’t know

16. If you forget to take one birth control pill and
remember the next day, what should you do?
a. Throw the missed pill away and then continue the
following day from where you left off
b. Take the rest of the week’s pills at once and then
start the placebo (“reminder”) week
c. Take two pills then continue
d. Throw the missed pill away and wait 1 month to
start a new pack
e. I don’t know
17. Which of the following is FALSE about Depo-Provera
(the “shot”)?
a. It is administered every 3 months
b. Gradual weight gain is possible
c. It might take a few months after stopping to become
pregnant
d. It cannot be used while breastfeeding
e. I don’t know

22. Which choice is FALSE about IUDs (intrauterine
devices)?
a.
Women of all ages may get an IUD
b.
Women who have never had a baby may get an
IUD
c.
Women can have an IUD put in right after
having a baby or having an abortion
d. Women cannot get an IUD if they have ever
had a sexually transmitted disease (STD)
e.
I don’t know
23. A provider places the birth control implant
(Nexplanon) in what part of the body?
a. Thigh
b. Vagina
c. Arm
d. Buttock
e. I don’t know

18. Which of the following birth control methods may be
reversed if you decide you want to become pregnant?
a. Tubal ligation (“tying your tubes” or “cutting your tubes”)
b. Essure coils
c. Vasectomy
d. IUD (intrauterine device)
e. I don’t know

24. How soon after sex must the “morning after pill”
(emergency contraception) be used to be effective?
a. 1 hour
b. 24 hours
c. 3 days
d. 20 days
e. I don’t know

21. Which method of birth control is the best at
preventing pregnancy?
a. The IUD (intrauterine device)
b. Depo-Provera (“the shot”)
c. Male condom
d. Withdrawal (“pull out method”)
e. They are equally effective
f.
I don’t know

25. How can you get the emergency contraception pill (i.e. the morning after pill)?
a. If under 18, you cannot get it, even with a prescription
b. If under 21, you must have your parent go with you to
the doctor for a prescription
c. All women must have a prescription, no matter her age
Note. Correct answers are in bold and italicized.
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d. You can buy it at the pharmacy, without
prescription, no matter what age
e. I don’t know

Table 4. Sample Characteristics
Patient Sample
Overall
OAT

PC

n=167
32.9  0.4

n=165
31.3  0.5

86

87

2
3

p
value

Female

Patient Sample X Sex

Male

Female

p
value

Male

p

OAT

PC

OAT

PC

n=85
32.1  0.6

n=84
30.3  0.8

n=82
33.8  0.6

n=81
32.2  0.7

n=169
31.2  0.5

n=163
33.0  0.5

85

87

85

88

86

85

85

2

3

2

2

1

4

2

2

2

5

2

5

1

2

2

7

8
10
7
9
7
9
8
Note. OAT: Opioid Agonist Treatment Sample. PC: Primary Care Sample. p values represent total two-way analysis of variance analysis.

10

5

Age (mean yrs. ± SE)

N=332
32.1 0.3

Sex

Race/Ethnicity (%)

White
Hispanic/
Latino
Black/African
American
Other

<.05
.29

<.01
.44

value

.89
.51
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100

100
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Figure 5. Mean Percent Correct on the Contraceptive Knowledge Assessment
(CKA) by Main Effects of Patient Sample (top left panel) and Sex (top right
panel) and Interaction (bottom panel).
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Table 5. Responses to Contraceptive Knowledge Assessment (CKA) Content Area Questions
Patient Sample
(Mean % Correct  SE)

Overall
OAT

PC

p
value

Sex
Female

Male

Patient Sample X Sex
p
value

Female
OAT

Male
PC

N=332
n=167
n=165
n=169
n=163
n=85
n=84
Fertility Awareness
<.01
<.01
53  1
49  2
58  2
58  2
48  2
53  3
62  3
(3 questions)
General Contraceptive Knowledge
<.001
<.01
66  1
62  2
70  2
70  2
62  2
67  2
72  3
(6 questions)
Short-Acting Contraception
.66
<.001
37  1
37  2
38  2
45  2
30  1
43  2
46  2
(9 questions)
Long-Acting Contraception
<.01
<.001
43  2
38  2
48  3
53  2
33  2
49  3
56  3
(3 questions)
Other Methods
<.01
.28
58  1
53  2
62  2
59  2
56  2
55  3
63  3
(4 questions)
Note. OAT: Opioid Agonist Treatment Sample. PC: Primary Care Sample. p values represent total two-way analysis of variance analysis.

OAT

PC

p
value

n=82
44  2

n=81
53  3

.97

57  2

68  3

.23

30  2

29  2

.48

27  3

39  4

.47

51  3

61  3

.71
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